Mooy CM - Search Results

1

Reduced melanoma-related mortality in uveal melanoma by preenucleation radiotherapy.

Kilic E, Stijnen T, de Jong PT, Mooy CM, Eijkenboom WM, Ringens PJ, Luyten GP. Kilic E, et al. Among authors: mooy cm. Arch Ophthalmol. 2005 Oct;123(10):1363-7. doi: 10.1001/archopht.123.10.1363. Arch Ophthalmol. 2005. PMID: 16219727

2

Concurrent loss of chromosome arm 1p and chromosome 3 predicts a decreased disease-free survival in uveal melanoma patients.

Kilic E, Naus NC, van Gils W, Klaver CC, van Til ME, Verbiest MM, Stijnen T, Mooy CM, Paridaens D, Beverloo HB, Luyten GP, de Klein A. Kilic E, et al. Among authors: mooy cm. Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2253-7. doi: 10.1167/iovs.04-1460. Invest Ophthalmol Vis Sci. 2005. PMID: 15980208

3

DNA flow cytometry in uveal melanoma: the effect of pre-enucleation irradiation.

Mooy C, Vissers K, Luyten G, Mulder A, Stijnen T, de Jong P, Bosman F. Mooy C, et al. Br J Ophthalmol. 1995 Feb;79(2):174-7. doi: 10.1136/bjo.79.2.174. Br J Ophthalmol. 1995. PMID: 7696240 Free PMC article.

4

Ki-67 immunostaining in uveal melanoma. The effect of pre-enucleation radiotherapy.

Mooy CM, de Jong PT, Van der Kwast TH, Mulder PG, Jager MJ, Ruiter DJ. Mooy CM, et al. Ophthalmology. 1990 Oct;97(10):1275-80. doi: 10.1016/s0161-6420(90)32420-x. Ophthalmology. 1990. PMID: 2243677

5

No demonstrated effect of pre-enucleation irradiation on survival of patients with uveal melanoma.

Luyten GP, Mooy CM, Eijkenboom WM, Stijnen T, Hellemons LP, Luider TM, de Jong PT. Luyten GP, et al. Among authors: mooy cm. Am J Ophthalmol. 1995 Jun;119(6):786-91. doi: 10.1016/s0002-9394(14)72786-2. Am J Ophthalmol. 1995. PMID: 7785695

6

Prognostic parameters in uveal melanoma: a review.

Mooy CM, De Jong PT. Mooy CM, et al. Surv Ophthalmol. 1996 Nov-Dec;41(3):215-28. doi: 10.1016/s0039-6257(96)80024-5. Surv Ophthalmol. 1996. PMID: 8970236 Review.

7

Late-onset retinoblastoma in a well-functioning fellow eye.

de Jong PT, Mooy CM, Stoter G, Eijkenboom WM, Luyten GP. de Jong PT, et al. Among authors: mooy cm. Ophthalmology. 2006 Jun;113(6):1040-4. doi: 10.1016/j.ophtha.2006.02.047. Epub 2006 May 2. Ophthalmology. 2006. PMID: 16631255

8

Clinical and cytogenetic analyses in uveal melanoma.

Kilic E, van Gils W, Lodder E, Beverloo HB, van Til ME, Mooy CM, Paridaens D, de Klein A, Luyten GP. Kilic E, et al. Among authors: mooy cm. Invest Ophthalmol Vis Sci. 2006 Sep;47(9):3703-7. doi: 10.1167/iovs.06-0101. Invest Ophthalmol Vis Sci. 2006. PMID: 16936076

9

Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.

Blom DJ, Luyten GP, Mooy C, Kerkvliet S, Zwinderman AH, Jager MJ. Blom DJ, et al. Invest Ophthalmol Vis Sci. 1997 Aug;38(9):1865-72. Invest Ophthalmol Vis Sci. 1997. PMID: 9286277

10

Element analysis of the early stages of age-related macular degeneration.

van der Schaft TL, de Bruijn WC, Mooy CM, Ketelaars DA, de Jong PT. van der Schaft TL, et al. Among authors: mooy cm. Arch Ophthalmol. 1992 Mar;110(3):389-94. doi: 10.1001/archopht.1992.01080150087034. Arch Ophthalmol. 1992. PMID: 1543459

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

80 results

Search Page